Tolemy Bio
About
What does Tolemy Bio do?
Tolemy Bio is a biotech startup developing Orbit, an AI-native platform designed to help researchers better understand, interpret, and optimize living cells for modern therapies and drug development. The platform aims to address the fragmentation and manual nature of current experimental workflows by connecting existing lab tools and data sources, incorporating virtual cell models, and utilizing AI research agents for analysis and decision-making. Their long-term goal is to build a virtual-cell…
What is Tolemy Bio's revenue?
StartupHub estimates Tolemy Bio's annual revenue at $430K (range $239K to $1.4M, 70% confidence), based on comparable companies in the sector.
What is Tolemy Bio's valuation?
StartupHub estimates Tolemy Bio's effective valuation at $5.3M (range $3.5M to $8.4M, 23% confidence), based on comparable companies in the sector.
How much funding has Tolemy Bio raised?
Tolemy Bio has raised a total of $1M in funding. The most recent round on record is Pre-Seed.
Where is Tolemy Bio headquartered?
Tolemy Bio is headquartered in Cambridge, England, United Kingdom.
When was Tolemy Bio founded?
Tolemy Bio was founded in 2022.
What industry does Tolemy Bio operate in?
Tolemy Bio operates in Biotechnology, Artificial Intelligence, Drug Discovery, Life Sciences, Biotech, AI-Driven Protein Design.
How many employees does Tolemy Bio have?
Tolemy Bio has approximately 4 people on record.
What is Tolemy Bio's current status?
Tolemy Bio's current operating status is: Inactive.
No comments yet. Be the first to share your take.